PHG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Given the user's beginner investment knowledge, long-term preference, and available capital, PHG is not a strong buy at the moment. While there are some positive technical indicators, the company's financial performance and lack of strong positive catalysts make it a better hold for now.
The technical indicators show a bullish trend with MACD positively expanding, RSI in the neutral zone, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 32.099), which could limit immediate upside potential.
The company's revenue increased by 10.32% YoY in Q4 2025, and gross margin improved by 15.31%, indicating operational efficiency gains. Technical indicators also show a bullish trend.
Net income dropped significantly by -228.70% YoY, and EPS fell by -226.32% YoY, reflecting poor profitability. Hedge funds have been aggressively selling the stock, and there are no significant insider or congress trades to provide confidence. Analyst ratings remain neutral, with limited upside in price targets.
In Q4 2025, revenue increased by 10.32% YoY to 5.93 billion EUR, but net income dropped by -228.70% YoY to 459.79 million EUR. EPS also declined by -226.32% YoY to 0.48 EUR. Gross margin improved to 44.88%, up 15.31% YoY, indicating some operational improvements despite profitability challenges.
Analyst ratings remain neutral, with recent price target increases to EUR 26 (Morgan Stanley) and EUR 22.60 (JPMorgan). However, these targets reflect limited upside, and analysts cite concerns about regulatory and execution risks, as well as lower sales growth potential.
